Alcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) P/B ratio
As of 5 November 2026, Alcon (ALC) trades at a P/B ratio of 1.7×. Over the past ten years it has ranged from 1.0× (March 2020) to 2.4× (September 2024); the current reading is higher than 39% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.8× | (9.41%) |
| FY2024 | 1.9× | 5.74% |
| FY2023 | 1.8× | 6.90% |
| FY2022 | 1.7× | (22.29%) |
| FY2021 | 2.2× | 29.33% |
| FY2020 | 1.7× | 19.82% |
| FY2019 | 1.4× | 14.31% |
| FY2018 | 1.3× | 0.00% |
| FY2017 | 1.3× | 0.00% |
| FY2016 | 1.3× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 1.5× | (8.83%) |
| Mar 2026 | 1.7× | (5.98%) |
| Dec 2025 | 1.8× | 6.03% |
| Sep 2025 | 1.7× | (15.78%) |
| 28 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| COO The Cooper Companies, Inc. compare | 1.5× |
| ALC Alcon | 1.7× |
| MDLN Medline Inc. compare | 1.8× |
| BAX Baxter International Inc. compare | 2.0× |
| BDX Becton, Dickinson and Company compare | 2.4× |
| ALGN Align Technology, Inc. compare | 2.7× |
| SOLV Solventum Corporation compare | 3.1× |
| RMD ResMed Inc. compare | 5.7× |
| WST West Pharmaceutical Services, Inc. compare | 9.3× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement